Changing Role of Medicare and its Impact on Pharmaceutical Industry

Changing Role of Medicare and its Impact on Pharmaceutical Industry

 

RELEASE DATE
26-Jul-2004
REGION
North America
Research Code: A920-01-00-00-00
SKU: HC00988-NA-MR_04886
AvailableYesPDF Download
$3,950.00
In stock
SKU
HC00988-NA-MR_04886
$3,950.00
DownloadLink
ENQUIRE NOW

Description

The objective of this report is to evaluate the present state of the healthcare industry with reference to Medicare and to evaluate the challenges and opportunities for the pharmaceutical industry becuase of Medicare modernization Act. Impact of Medicare Prescription Drug Law has been evaluated and implications of the law for various healthcare segments has been analyzed. Frost & Sullivan Awards are given to the industry's outstanding achievers.

Table of Contents

Overview

  • Introduction
  • Disclaimer
  • Certification
  • Research Scope and Methodology

Basics of Medicare

  • Medicare - The Basics
  • Medicare Beneficiaries
  • Medicare Part A
  • Medicare Part B
  • Medicare + Choice
  • 2004 Medicare Service Spending

Current State of Medicare

  • Issues with Medicare
  • Senior Prescription Drug Coverage
  • The Need For Change
  • Executive Quote

Medicare Prescription Drug Legislation

Impact on Different Segments of the Healthcare Industry

Introduction

Medicare Spending on Prescription Drugs

Business Planning and Strategic Thinking

Perceived Impact on Pharmaceutical Revenues

  • Important Changes Affecting Pharmaceuticals
  • Potential Threats
  • Medicare Part B Reimbursement Issues

Frost and Sullivan Awards

  • Forecasts of Beneficiaries with Prescription Coverage
  • Analysis of Medicare Beneficiaries with Prescription Drug Benefits
  • Dual Eligibles
  • Low-Income Assistance
  • Prescription Drug Spending
  • Analysis of Prescription Drug Spending - I
  • Analysis of Prescription Drug Spending - II
  • Medicare Spending
  • Analysis of Medicare Spending
  • Impact of Medicare Reform on Rheumatoid Arthritis Markets
  • Oncology Drug Reimbursement Overview
  • Impact of Medicare Reform on Oncology Drug Reimbursement
  • Implications of Prescription Drug Law
  • CMS Administrator Quote

Decision Support Databases

  • Achieving Sustained Value Growth
  • Capturing Opportunity and Avoiding Strategic Risk
  • Already Known to 2010 and Beyond
  • Meeting the Challenge
  • Complying with Medicare
  • Strategic Thinking and Analysis
  • Anticipating the Future
  • Executive Quote

Frost and Sullivan

  • Market Expansion
  • Reaction to the Medicare Legislation
  • Implications for Pharmaceutical Companies
  • Challenges for Pharmaceutical Companies
  • Executive Quote
  • How The Medicare Drug Benefit Affects Pharmaceutical Revenues
  • Reduced Impact of Prescription Drug Benefit
  • Critical Evaluation - I
  • Critical Evaluation - II
Related Research
The objective of this report is to evaluate the present state of the healthcare industry with reference to Medicare and to evaluate the challenges and opportunities for the pharmaceutical industry becuase of Medicare modernization Act. Impact of Medicare Prescription Drug Law has been evaluated and implications of the law for various healthcare segments has been analyzed. Frost & Sullivan Awards are given to the industry's outstanding achievers.
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number A920-01-00-00-00
Is Prebook No